Chapter 018

Histamine and Histamine Antagonists

Matthew R. Cooke and Joseph A. Giovannitti Jr.

GENERAL REFERENCES

  1. Church MK, Church DS: Pharmacology of antihistamines, Indian J Dermatol 58(3):219–224, May 2013, http://dx.doi.org/10.4103/0019-5154.110832. http://www.ncbi.nlm.nih.gov/pubmed/23831018-comments. PUBMED Abstract
  2. Monczor F, Fernandez N, Fitzsimons CP, Shayo C, Davio C: Antihistaminergics and inverse agonism: potential therapeutic applications, Eur J Pharmacol 715(1–3):26–32, September 5, 2013. http://dx.doi.org/10.1016/j.ejphar.2013.06.027. Epub July 4, 2013. PUBMED Abstract
  3. Tabarean IV: Histamine receptor signaling in energy homeostasis, Neuropharmacology, June 21, 2015. http://dx.doi.org/10.1016/j.neuropharm.2015.04.011. pii:S0028-3908(15)00140-9; Epub ahead of print. PUBMED Abstract
  4. Thurmond RL: The histamine H4 receptor: from orphan to the clinic, Front Pharmacol 6:65, March 31, 2015. http://dx.doi.org/10.3389/ fphar.2015.00065. PUBMED Abstract